Capital World Investors Novo Cure LTD Transaction History
Capital World Investors
- $625 Billion
- Q3 2024
A detailed history of Capital World Investors transactions in Novo Cure LTD stock. As of the latest transaction made, Capital World Investors holds 4,308,218 shares of NVCR stock, worth $131 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,308,218
Previous 2,308,215
86.65%
Holding current value
$131 Million
Previous $39.5 Million
70.31%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$370 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$361 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$242 Million0.02% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$92.4 Million12.67% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$85.6 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.2B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...